Literature DB >> 15004089

Resistance of group B streptococcus to selected antibiotics, including erythromycin and clindamycin.

Judith S Heelan1, Meredith E Hasenbein, Alexander J McAdam.   

Abstract

Resistance of group B streptococcus (GBS) to antibiotics, particularly erythromycin and clindamycin, was studied. Erythromycin resistance was present in 22% of GBS isolates, and these isolates were constitutively resistant, inducibly resistant, or sensitive to clindamycin. Erythromycin and clindamycin MICs were related to the presence of ermA, ermB, or mefA genes.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15004089      PMCID： PMC356858          DOI： 10.1128/JCM.42.3.1263-1264.2004

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  13 in total

1.  Prevalence and mechanisms of macrolide resistance in clinical isolates of group A streptococci from Ontario, Canada.

Authors:  J C De Azavedo; R H Yeung; D J Bast; C L Duncan; S B Borgia; D E Low
Journal:  Antimicrob Agents Chemother       Date:  1999-09       Impact factor: 5.191

2.  Presence of mefA and mefE genes in Streptococcus agalactiae.

Authors:  C Arpin; H Daube; F Tessier; C Quentin
Journal:  Antimicrob Agents Chemother       Date:  1999-04       Impact factor: 5.191

3.  Bacterial resistance: origins, epidemiology, and impact.

Authors:  David M Livermore
Journal:  Clin Infect Dis       Date:  2003-01-15       Impact factor: 9.079

4.  Revised guidelines for prevention of early-onset group B streptococcal (GBS) infection. American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn.

Authors: 
Journal:  Pediatrics       Date:  1997-03       Impact factor: 7.124

5.  Antibiotic resistance patterns of group B streptococci in pregnant women.

Authors:  K Berkowitz; J A Regan; E Greenberg
Journal:  J Clin Microbiol       Date:  1990-01       Impact factor: 5.948

Review 6.  Mechanisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications.

Authors:  Roland Leclercq
Journal:  Clin Infect Dis       Date:  2002-01-11       Impact factor: 9.079

7.  Use of clindamycin disks To detect macrolide resistance mediated by ermB and mefE in Streptococcus pneumoniae isolates from adults and children.

Authors:  K Waites; C Johnson; B Gray; K Edwards; M Crain; W Benjamin
Journal:  J Clin Microbiol       Date:  2000-05       Impact factor: 5.948

8.  Antimicrobial susceptibilities of group B streptococci isolated from patients with invasive disease: 10-year perspective.

Authors:  D R Murdoch; L B Reller
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

9.  Prevalence and mechanisms of macrolide resistance in invasive and noninvasive group B streptococcus isolates from Ontario, Canada.

Authors:  J C de Azavedo; M McGavin; C Duncan; D E Low; A McGeer
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

10.  Erythromycin-resistant group A streptococcal isolates recovered in Sofia, Bulgaria, from 1995 to 2001.

Authors:  Antoaneta Detcheva; Richard R Facklam; Bernard Beall
Journal:  J Clin Microbiol       Date:  2002-10       Impact factor: 5.948
View more
  39 in total

1.  High rates of perinatal group B Streptococcus clindamycin and erythromycin resistance in an upstate New York hospital.

Authors:  Ephraim E Back; Elisa J O'Grady; Joshua D Back
Journal:  Antimicrob Agents Chemother       Date:  2011-12-05       Impact factor: 5.191

Review 2.  Molecular-based screening for perinatal group B streptococcal infection: implications for prevention and therapy.

Authors:  Stéphane Emonet; Jacques Schrenzel; Begoña Martinez de Tejada
Journal:  Mol Diagn Ther       Date:  2013-12       Impact factor: 4.074

3.  Structure of Streptococcus agalactiae tip pilin GBS104: a model for GBS pili assembly and host interactions.

Authors:  Vengadesan Krishnan; Prabhat Dwivedi; Brandon J Kim; Alexandra Samal; Kevin Macon; Xin Ma; Arunima Mishra; Kelly S Doran; Hung Ton-That; Sthanam V L Narayana
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2013-05-15

4.  Genetic heterogeneity in pbp genes among clinically isolated group B Streptococci with reduced penicillin susceptibility.

Authors:  Noriyuki Nagano; Yukiko Nagano; Kouji Kimura; Kiyoko Tamai; Hideji Yanagisawa; Yoshichika Arakawa
Journal:  Antimicrob Agents Chemother       Date:  2008-09-22       Impact factor: 5.191

5.  Emergence of the first levofloxacin-resistant strains of Streptococcus agalactiae isolated in Italy.

Authors:  G Piccinelli; F Gargiulo; S Corbellini; G Ravizzola; C Bonfanti; A Caruso; M A De Francesco
Journal:  Antimicrob Agents Chemother       Date:  2015-02-09       Impact factor: 5.191

6.  Antimicrobial susceptibilities of group B streptococcus isolates from prenatal screening samples.

Authors:  Benjamin R Berg; Jeana L Houseman; Zachary E terSteeg; William D LeBar; Duane W Newton
Journal:  J Clin Microbiol       Date:  2014-07-16       Impact factor: 5.948

7.  The crystal structure analysis of group B Streptococcus sortase C1: a model for the "lid" movement upon substrate binding.

Authors:  Baldeep Khare; Zheng-Qing Fu; I-Hsiu Huang; Hung Ton-That; Sthanam V L Narayana
Journal:  J Mol Biol       Date:  2011-10-18       Impact factor: 5.469

8.  Synergistic effect between two bacteriocin-like inhibitory substances produced by Lactobacilli Strains with inhibitory activity for Streptococcus agalactiae.

Authors:  Francisco O Ruíz; Gisela Gerbaldo; María J García; Walter Giordano; Liliana Pascual; Isabel L Barberis
Journal:  Curr Microbiol       Date:  2012-01-10       Impact factor: 2.188

9.  Epidemiology of Invasive Group B Streptococcal Disease in Alberta, Canada, from 2003 to 2013.

Authors:  Areej Alhhazmi; Donna Hurteau; Gregory J Tyrrell
Journal:  J Clin Microbiol       Date:  2016-04-20       Impact factor: 5.948

10.  Isolation of quinupristin/dalfopristin-resistant Streptococcus agalactiae from asymptomatic Korean women.

Authors:  Hye Ran Nam; Hak Mee Lee; Yeonhee Lee
Journal:  J Microbiol       Date:  2008-02       Impact factor: 3.422
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.